Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation
Public ClinicalTrials.gov record NCT04856904. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Risk of Atrophic Acne Scar Formation During Treatment of Acne Vulgaris Subjects With Trifarotene 50 μg/g Cream Versus Vehicle Cream Over 24 Weeks
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle on the risk of formation of atrophic acne scars after 24 weeks of treatment in facial acne participants assessed by atrophic acne scars count.
Study identification
- NCT ID
- NCT04856904
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 17 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 27, 2021
- Primary completion
- Feb 7, 2023
- Completion
- Jun 29, 2023
- Last update posted
- Jun 10, 2024
2021 – 2023
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site #8873 | Scottsdale | Arizona | 85260 | — |
| Galderma Investigational Site #8447 | Fort Smith | Arkansas | 72916 | — |
| Galderma Investigational Site #8608 | Santa Monica | California | 90404 | — |
| Galderma Investigational Site #9928 | Boynton Beach | Florida | 33437 | — |
| Galderma Investigational Site #8295 | Miami | Florida | 33136 | — |
| Galderma Investigational Site #8883 | Miramar | Florida | 33027 | — |
| Galderma Investigational Site #8189 | Snellville | Georgia | 30078 | — |
| Galderma Investigational Site #8367 | Arlington Heights | Illinois | 60005 | — |
| Galderma Investigational Site #8838 | Darien | Illinois | 60561 | — |
| Galderma Investigational Site #8601 | Metairie | Louisiana | 70001 | — |
| Galderma Investigational Site #9936 | New Orleans | Louisiana | 70130 | — |
| Galderma Investigational Site #8108 | Las Vegas | Nevada | 89148 | — |
| Galderma Investigational Site #8881 | Stony Brook | New York | 11790 | — |
| Galderma Investigational Site #8886 | Sugarloaf | Pennsylvania | 18249 | — |
| Galderma Investigational Site #9920 | Arlington | Texas | 76011 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04856904, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 10, 2024 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04856904 live on ClinicalTrials.gov.